Is it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsy

Urology Journal

Volumn 9, Issue 2, 2012, Pages 491-497

  Yoon, Byung Il ^a   Shin, Tae Seung ^a   Cho, Hyuk Jin ^a   Hong, Sung Hoo ^a   Lee, Ji Youl ^a   Hwang, Tae Kon ^a   Kim, Sae Woong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Biopsy; Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BIOPSY; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FAINTNESS; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PROSTATITIS; RANDOMIZED CONTROLLED TRIAL; RECTUM DISEASE;

AGED; BIOPSY; DIGITAL RECTAL EXAMINATION; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; RECTAL DISEASES; SYNCOPE, VASOVAGAL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84864114443     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random sys tematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142:71-4; discussion 4-5.
2. Naughton CK, Smith DS, Humphrey PA, Catalona WJ, Keetch DW. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. Urology. 1998;52:808-13.
3. Levine MA, Ittman M, Melamed J, Lepor H. Two consecu tive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159:471 -5; discussion 5-6.
4. Loch T, Eppelmann U, Lehmann J, Wullich B, Loch A, Stockle M. Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions. World J Urol. 2004;22:357-60.
5. MacMahon PJ, Kennedy AM, Murphy DT, Maher M, McNich-olas MM. Modified prostate volume algorithm improves transrectal US volume estimation in men presenting for prostate brachytherapy. Radiology. 2009;250:273-80.
6. Song C, Ahn H, Lee MS, et al. Mass screening for pros tate cancer in Korea: a population based study. J Urol. 2008;180:1949-52; discussion 52-3.
7. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997;50:562-6.
8. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol. 2000;164:393-6.
9. Lee SB, Kim CS. Comparative analysis of sextant and ex tended prostate biopsy. Korean J Urol. 2004;45:524-9.
10. Moon KH, Cheon SH, Kim CS. Systematic 10-site prostate biopsy is superior to sextant method for diagnosing carci noma of the prostate. Korean J Urol. 2000;41:1178-82.
11. Presti JC, Jr., O'Dowd GJ, Miller MC, Mattu R, Veltri RW. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a commu nity multi-practice study. J Urol. 2003;169:125-9.
12. Bae KS, Chang SG. Comparative analysis between sextant biopsy and 12-samples needle biopsy for detection of stage T1 c prostate cancer. Korean J Urol. 2004;45:653-7.
13. Presti JC, Jr., Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 2000;163:163-6; discussion 6-7.
14. Durkan GC, Sheikh N, Johnson P, Hildreth AJ, Greene DR. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int. 2002;89:33-9.
15. Rochester MA, Griffin S, Chappell B, McLoughlin J. A pro spective randomised trial of extended core prostate biopsy protocols utilizing 12 versus 15 cores. Urol Int. 2009;83:155-9.
16. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol. 2000;164:388-92.
17. Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Gal-luzzi C, Jones JS. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy. J Urol. 2008;179:1746-50; discussion 50.
18. Pepe P, Aragona F. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology. 2007;70:1131-5.
19. Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhance ment of specificity with free PSA measurements. JAMA. 1997;277:1452-5.
20. Karakiewicz PI, Bazinet M, Aprikian AG, et al. Outcome of sextant biopsy according to gland volume. Urology. 1997;49:55-9.
21. Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED, Jr. The influence of prostate size on cancer detection. Urology. 1995;46:831-6.
22. Mariappan P, Chong WL, Sundram M, Mohamed SR. Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clini cal study on cancer detection rates and morbidity. BJU Int. 2004;94:307-10.
23. Djavan B, Waldert M, Zlotta A, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol. 2001;166:856-60.